A LOW DOSE GLUCOCORTICOID, LOW DOSE CYCLOPHOSPHAMIDE, RITUXIMAB TREATMENT PROTOCOL AS INDUCTION THERAPY IN ANCA ASSOCIATED VASCULITIS PATIENTS

被引：0
|
作者：
Spanos, Georgios [1 ]
Paschou, Styliani [1 ]
Bakou, Marianna [1 ]
Atalla, Alexandros [1 ]
Bantis, Christos [1 ]
Fragidis, Stylianos [1 ]
Armetzoiou, Livia Karmen [1 ]
Bamichas, Gerasimos [1 ]
机构：
[1] Gen Hosp Thessaloniki G Papanikolaou, Dept Nephrol, Thessaloniki, Greece
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5835
引用
收藏
页码：I405 / I406
页数：2
相关论文
共 50 条
  • [21] Single dose of rituximab for ANCA-associated vasculitis
    Nature Reviews Rheumatology, 2014, 10 (5) : 258 - 258
  • [22] LONG-TERM FOLLOW-UP OF A COMBINED RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE REGIMEN FOR REMISSION INDUCTION IN RENAL ANCA-ASSOCIATED VASCULITIS
    McAdoo, Stephen Paul
    Gopaluni, Seerapani
    Medjeral-Thomas, Nicholas
    Tanna, Anisha
    Griffith, Megan
    Levy, Jeremy
    Cook, Terence
    Cairns, Thomas
    Salama, Alan
    Jayne, David
    Pusey, Charles
    RHEUMATOLOGY, 2017, 56 : 153 - 153
  • [23] A SINGLE CENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY BETWEEN LOW-DOSE VERSUS HIGH-DOSE RITUXIMAB AS REMISSION INDUCTION THERAPY IN JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Hirose, Kei
    Hirata, Manami
    Yamamura, Yuriko
    Ueno, Akiko
    Yamamura, Masahiro
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1756 - 1756
  • [24] A Single Center Retrospective Analysis of Efficacy and Safety Between Low-Dose versus High-Dose Rituximab as Remission Induction Therapy with ANCA-Associated Vasculitis
    Hirose, Kei
    Hirata, Manami
    Ueno, Akiko
    Yamamura, Masahiro
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [25] Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients
    Moog, P.
    Probst, M.
    Kuechle, C.
    Hauser, C.
    Heemann, U.
    Thuermel, K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (06) : 519 - 523
  • [26] RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY
    Von Allwoerden, K.
    Klapa, S.
    Werth, S. C.
    Mueller, A.
    Riemekasten, G.
    Nitschke, M.
    Thaci, D.
    Lamprecht, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 912 - 913
  • [27] ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients
    van Dam, Laura
    Dirikgil, Ebru
    Bredewold, Edwin
    Ray, Argho
    Rabelink, Ton
    van Kooten, Cees
    Teng, Onno
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [28] Long-term outcome of low dose cyclophosphamide (CYC) and plasma exchange (PLEX) induction in ANCA-associated vasculitis (AAV)
    Szpirt, W.
    Krarup, E.
    Egfjord, M.
    PRESSE MEDICALE, 2013, 42 (04): : 754 - 754
  • [29] Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis
    Dhaygude, A
    Griffith, M
    Cairns, T
    McLean, A
    Palmer, A
    Taube, D
    NEPHRON CLINICAL PRACTICE, 2004, 97 (04): : C154 - C159
  • [30] Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis
    Gulati, Kavita
    Edwards, Helena
    Prendecki, Maria
    Cairns, Thomas D.
    Condon, Marie
    Galliford, Jack
    Griffith, Megan
    Levy, Jeremy B.
    Tam, Frederick W. K.
    Tanna, Anisha
    Pusey, Charles D.
    McAdoo, Stephen P.
    KIDNEY INTERNATIONAL, 2021, 100 (06) : 1316 - 1324
12345